Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Takako Suzuki, Yukio Nakamura & Hiroyuki Kato. (2018) Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis. Therapeutics and Clinical Risk Management 14, pages 453-459.
Read now
Read now
Koji Takasugi, Keiichiro Nishida, Masamitsu Natsumeda, Misuzu Yamashita, Wataru Yamamoto & Kazuhiko Ezawa. (2018) IL-6 is an independent predictive factor of drug survival after dose escalation of infliximab in patients with rheumatoid arthritis. Modern Rheumatology 28:3, pages 452-460.
Read now
Read now
Eleftherios Pelechas, Paraskevi V. Voulgari & Alexandros A. Drosos. (2017) Sirukumab: a promising therapy for rheumatoid arthritis. Expert Opinion on Biological Therapy 17:6, pages 755-763.
Read now
Read now
Allison B. Reiss, Nicolle M. Siegart & Joshua De Leon. (2017) Interleukin-6 in atherosclerosis: atherogenic or atheroprotective?. Clinical Lipidology 12:1, pages 14-23.
Read now
Read now
Pietro Enea Lazzerini, Pier Leopoldo Capecchi, Giacomo Maria Guidelli, Enrico Selvi, Maurizio Acampa & Franco Laghi-Pasini. (2016) Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date. Drug Design, Development and Therapy 10, pages 3083-3098.
Read now
Read now
Articles from other publishers (39)
Mohammad Yasin Zamanian, Maryam Golmohammadi, Ali Alalak, Zahra Kamiab, Rasha Obaid, Andrés Alexis Ramírez-Coronel, Ahmed Hjazi, Munther Abosaooda, Yasser Mustafa, Mahsa Heidari, Amita Verma, Yashar Nazari & Gholamreza Bazmandegan. (2023) STAT3 Signaling Axis and Tamoxifen in Breast Cancer: A Promising Target for
Treatment Resistance. Anti-Cancer Agents in Medicinal Chemistry 23:16, pages 1819-1828.
Crossref
Crossref
Kelsee K. Zajac, Saloni Malla, Ramapuram Jayachandra Babu, Dayanidhi Raman & Amit K. Tiwari. (2023) Ethnic disparities in the immune microenvironment of triple negative breast cancer and its role in therapeutic outcomes. Cancer Reports 6:S1.
Crossref
Crossref
Yiying Xue, Husheng Mei, Yisa Chen, James D. Griffin, Qingsong Liu, Ellen Weisberg & Jing Yang. (2023) Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2. MedComm 4:3.
Crossref
Crossref
Ahmadreza Khoshroo, Keyvan Ramezani, Niusha Moghimi, Moein Bonakdar & Nazanin Ramezani. (2022) The effect of disease-modifying antirheumatic drugs (DMARDs) on bone homeostasis in rheumatoid arthritis (RA) patients. Inflammopharmacology 31:2, pages 689-697.
Crossref
Crossref
Jingqin Chen, Zhihua Xie, Liang Song, Xiaojing Gong & Chengbo Liu. 2023. Imaging Inflammation. Imaging Inflammation
191
221
.
Takashi Mochizuki, Kaito Shibata, Takafumi Naito, Kumiko Shimoyama, Noriyoshi Ogawa, Masato Maekawa & Junichi Kawakami. (2022) LC-MS/MS method for the quantitation of serum tocilizumab in rheumatoid arthritis patients using rapid tryptic digestion without IgG purification. Journal of Pharmaceutical Analysis 12:6, pages 852-859.
Crossref
Crossref
Simon Kuster, Suzana Jordan, Muriel Elhai, Ulrike Held, Klaus Steigmiller, Cosimo Bruni, Fabio Cacciapaglia, Serena Vettori, Elise Siegert, Simona Rednic, Veronica Codullo, Paolo Airo, Yolanda Braun-Moscovici, Nicolas Hunzelmann, Maria Joao Salvador, Valeria Riccieri, Ana-Maria Gheorghiu, Juan José Alegre Sancho, Katarzyna Romanowska-Prochnicka, Ivan Castellví, Ina Kötter, Marie-Elise Truchetet, FJ López-Longo, Pavel I Novikov, Alessandro Giollo, Yuichiro Shirai, Laura Belloli, Elisabetta Zanatta, Eric Hachulla, Vanessa Smith, Chris Denton, Ruxandra M Ionescu, Tim Schmeiser, Joerg H W Distler, Armando Gabrielli, Anna-Maria Hoffmann-Vold, Masataka Kuwana, Yannick Allanore & Oliver Distler. (2022) Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort. RMD Open 8:2, pages e002477.
Crossref
Crossref
Wei Lin, Gang Chen, Yuhang Mao, Xuemei Ma, Junnan Zhou, Xiaolu Yu, Chaoliang Wang & Mei Liu. (2022)
Imperatorin Inhibits Proliferation, Migration, and Inflammation
via
Blocking the NF-κB and MAPK Pathways in Rheumatoid Fibroblast-like Synoviocytes
. ACS Omega 7:34, pages 29868-29876.
Crossref
Crossref
Roula Antoon, Xing-Hua Wang, Amr H. Saleh, Jenny Warrington, David W Hedley & Armand Keating. (2022) Pancreatic cancer growth promoted by bone marrow mesenchymal stromal cell–derived IL-6 is reversed predominantly by IL-6 blockade. Cytotherapy 24:7, pages 699-710.
Crossref
Crossref
Shital Vishnu Patil, Gajanan Gondhali & Abhijit Acharya. (2022) Role of initial and follow-up IL-6 (Interleukin-6) titre in COVID-19 pneumonia: A single center experience. Electronic Journal of General Medicine 19:5, pages em390.
Crossref
Crossref
Susmita Srivastava & Mahaboobkhan Rasool. (2022) Underpinning IL-6 biology and emphasizing selective JAK blockade as the potential alternate therapeutic intervention for rheumatoid arthritis. Life Sciences 298, pages 120516.
Crossref
Crossref
Ho Tsoi, Ellen P. S. Man, Ka Man Chau & Ui-Soon Khoo. (2021) Targeting the IL-6/STAT3 Signalling Cascade to Reverse Tamoxifen Resistance in Estrogen Receptor Positive Breast Cancer. Cancers 13:7, pages 1511.
Crossref
Crossref
Yongya Li, Hayam Mansour, Colton J. F. Watson, Yanan Tang, Adam J. MacNeil & Feng Li. (2021) Amplified detection of nucleic acids and proteins using an isothermal proximity CRISPR Cas12a assay. Chemical Science 12:6, pages 2133-2137.
Crossref
Crossref
Ankelien Duchow & Judith Bellmann-Strobl. (2021) Satralizumab in the treatment of neuromyelitis optica spectrum disorder. Neurodegenerative Disease Management 11:1, pages 49-59.
Crossref
Crossref
Paul M. Elsbernd, William R. Hoffman, Jonathan L. Carter & Dean M. Wingerchuk. (2021) Interleukin-6 inhibition with tocilizumab for relapsing MOG-IgG associated disorder (MOGAD): A case-series and review. Multiple Sclerosis and Related Disorders 48, pages 102696.
Crossref
Crossref
Joseph Lorenzo. 2021. Marcus and Feldman's Osteoporosis. Marcus and Feldman's Osteoporosis
799
831
.
Itay Lotan, Richard McGowan & Michael Levy. (2020) Anti-IL-6 Therapies for Neuromyelitis Optica Spectrum Disorders: A Systematic Review of Safety and Efficacy. Current Neuropharmacology 19:2, pages 220-232.
Crossref
Crossref
Dalia M. E. El-Mikkawy, Maha A. EL-Sadek, Mohja A. EL-Badawy & Dalia Samaha. (2020) Circulating level of interleukin-6 in relation to body mass indices and lipid profile in Egyptian adults with overweight and obesity. Egyptian Rheumatology and Rehabilitation 47:1.
Crossref
Crossref
Misato Hashizume. (2020) Outlook of IL-6 signaling blockade for COVID-19 pneumonia. Inflammation and Regeneration 40:1.
Crossref
Crossref
Lixian Liu, Junjing Jia, Min Jiang, Xueping Liu, Chenling Dai, Barton L. Wise, Nancy E. Lane & Wei Yao. (2020) High susceptibility to collagen-induced arthritis in mice with progesterone receptors selectively inhibited in osteoprogenitor cells. Arthritis Research & Therapy 22:1.
Crossref
Crossref
Bahaa Abu-Raya, Giovanni Battista Migliori, Miguel O'Ryan, Kathryn Edwards, Antoni Torres, Jan-Willem Alffenaar, Anne-Grete Märtson, Rosella Centis, Lia D'Ambrosio, Katie Flanagan, Ivan Hung, Fulvio Lauretani, Chi Chi Leung, Elke Leuridan, Kirsten Maertens, Marcello Giuseppe Maggio, Simon Nadel, Niel Hens, Hubert Niesters, Albert Osterhaus, Emanuele Pontali, Nicola Principi, Denise Rossato Silva, Saad Omer, Antonio Spanevello, Nicola Sverzellati, Tina Tan, Juan Pablo Torres-Torreti, Dina Visca & Susanna Esposito. (2020) Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid). Frontiers in Medicine 7.
Crossref
Crossref
Jie Zheng, Valeriia Haberland, Denis Baird, Venexia Walker, Philip C. Haycock, Mark R. Hurle, Alex Gutteridge, Pau Erola, Yi Liu, Shan Luo, Jamie Robinson, Tom G. Richardson, James R. Staley, Benjamin Elsworth, Stephen Burgess, Benjamin B. Sun, John Danesh, Heiko Runz, Joseph C. Maranville, Hannah M. Martin, James Yarmolinsky, Charles Laurin, Michael V. Holmes, Jimmy Z. Liu, Karol Estrada, Rita Santos, Linda McCarthy, Dawn Waterworth, Matthew R. Nelson, George Davey Smith, Adam S. Butterworth, Gibran Hemani, Robert A. Scott & Tom R. Gaunt. (2020) Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nature Genetics 52:10, pages 1122-1131.
Crossref
Crossref
Linzi Fan, Shuang Jiang, Xinrong Yang, Zhibin Wang & Chunjuan Yang. (2020) COVID-19 Drug Treatment in China. Current Pharmacology Reports 6:4, pages 146-154.
Crossref
Crossref
Yue Zhang, Qianhao Xu, Zhuoyan Sun & Lei Zhou. (2020) Current targeted therapeutics against COVID-19: Based on first-line experience in China. Pharmacological Research 157, pages 104854.
Crossref
Crossref
Ernest H. Choy, Fabrizio De Benedetti, Tsutomu Takeuchi, Misato Hashizume, Markus R. John & Tadamitsu Kishimoto. (2020) Translating IL-6 biology into effective treatments. Nature Reviews Rheumatology 16:6, pages 335-345.
Crossref
Crossref
Itay Lotan, Robert W. Charlson, Lana Zhovtis Ryerson, Michael Levy & Ilya Kister. (2020) Effectiveness of subcutaneous tocilizumab in neuromyelitis optica spectrum disorders. Multiple Sclerosis and Related Disorders 39, pages 101920.
Crossref
Crossref
Joseph Lorenzo. 2020. Bone Regulators and Osteoporosis Therapy. Bone Regulators and Osteoporosis Therapy
177
230
.
Neety Sahu, Hendrik J. Viljoen & Anuradha Subramanian. (2019) Continuous low-intensity ultrasound attenuates IL-6 and TNFα-induced catabolic effects and repairs chondral fissures in bovine osteochondral explants. BMC Musculoskeletal Disorders 20:1.
Crossref
Crossref
Sabine Adler, Stephan Reichenbach, Andrea Gloor, Daniel Yerly, Jennifer L. Cullmann & Peter M. Villiger. (2019) Risk of relapse after discontinuation of tocilizumab therapy in giant cell arteritis. Rheumatology 58:9, pages 1639-1643.
Crossref
Crossref
Chun-yan Wang, Shao-hua Guo, Li-ping Wang & Hai-li Shen. (2019) Refractory adult-onset Still disease treated by tocilizumab combined with methotrexate. Medicine 98:32, pages e16682.
Crossref
Crossref
Ademuyiwa S. Aromolaran, Ujala Srivastava, Alessandra Alí, Mohamed Chahine, Deana Lazaro, Nabil El-Sherif, Pier Leopoldo Capecchi, Franco Laghi-Pasini, Pietro Enea Lazzerini & Mohamed Boutjdir. (2018) Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation. PLOS ONE 13:12, pages e0208321.
Crossref
Crossref
Laurence S. C. Lok, Neda Farahi, Jatinder K. Juss, Chrystalla Loutsios, Chandra K. Solanki, Adrien M. Peters, Francis Donaldson, Benjamin Porter-Brown & Edwin R. Chilvers. (2017) Effects of tocilizumab on neutrophil function and kinetics. European Journal of Clinical Investigation 47:10, pages 736-745.
Crossref
Crossref
Brooke I. Polk & Lanny J. Rosenwasser. (2017) Biological Therapies of Immunologic Diseases. Immunology and Allergy Clinics of North America 37:2, pages 247-259.
Crossref
Crossref
Jose A. Figueroa, Camilo Pena, Leonardo Mirandola, Adair Reidy, J. Drew Payne, Nattamol Hosiriluck, Natallia Suvorava, Rakhshanda Layeequr Rahman, Adrienne R. Whitlow, Rashmi Verma, Everardo Cobos & Maurizio Chiriva-Internati. 2016. Biosimilars of Monoclonal Antibodies. Biosimilars of Monoclonal Antibodies
113
153
.
Judith Land, Wayel H. Abdulahad, Jan-Stephan F. Sanders, Coen A. Stegeman, Peter Heeringa & Abraham Rutgers. (2016) Regulatory and effector B cell cytokine production in patients with relapsing granulomatosis with polyangiitis. Arthritis Research & Therapy 18:1.
Crossref
Crossref
Christian T. RuffRobert P. GiuglianoElliott M. Antman. (2016) Management of Bleeding With Non–Vitamin K Antagonist Oral Anticoagulants in the Era of Specific Reversal Agents. Circulation 134:3, pages 248-261.
Crossref
Crossref
Jie Yang, Shihui Qian, Xueting Cai, Wuguang Lu, Chunping Hu, Xiaoyan Sun, Yang Yang, Qiang Yu, S. Paul Gao & Peng Cao. (2016) Chikusetsusaponin IVa Butyl Ester (CS-IVa-Be), a Novel IL6R Antagonist, Inhibits IL6/STAT3 Signaling Pathway and Induces Cancer Cell Apoptosis. Molecular Cancer Therapeutics 15:6, pages 1190-1200.
Crossref
Crossref
Weirong Wang, Thomas S. McIntosh, Xiling Jiang, Rajitha Doddareddy, Elayne C. Dell & Honghui Zhou. (2015) Deciphering the In Vivo Performance of a Monoclonal Antibody to Neutralize Its Soluble Target at the Site of Action in a Mouse Collagen-Induced Arthritis Model. Pharmaceutical Research 33:4, pages 1040-1049.
Crossref
Crossref
Joseph Lorenzo. 2016. Osteoimmunology. Osteoimmunology
143
167
.